Pfizer will embed a Chai platform instance trained on proprietary datasets, signaling deeper operational integration than typical external AI service usage and potentially accelerating biologics ...

ast June, when AI drug discovery startup Chai Discovery was just 15 months old, it released a new model that could design antibodies. Nearly 20 pharma companies reached out to talk. “It was like we ...